Breathe Well Live Well
Business Wire (press release) |
3 out of 4 people with symptomatic asthma report reduced productivity at work
Business Wire (press release) Results were released today by Boehringer Ingelheim from an international survey, providing new insight into the negative impact of persistent asthma symptoms on people's work productivity and their ability to perform everyday activities. The Work … |
View full post on asthma – Google News
|
Dignity Health Improves Asthma Outcomes with Use of Digital Health Technology
Business Wire (press release) SAN FRANCISCO–(BUSINESS WIRE)–Dignity Health, one of the nation's largest health care systems, announced results from a randomized controlled study which demonstrated that the use of digital health technology improved asthma control. The study … |
View full post on asthma – Google News
|
Asthma Therapeutics in Asia-Pacific Markets to 2021 – Launch of Late-Stage Biologics will Drive the Market in Spite …
Business Wire (press release) Over the 2015-2021 forecast period, the asthma therapeutics market in the Asia-Pacific region is expected to increase in value at a Compound Annual Growth Rate (CAGR) of 7.2%, from $3.5 billion to over $5.6 billion. Analysis of clinical trials since … |
View full post on asthma – Google News
|
SPIRIVA® RESPIMAT® Now Available in the U.S. for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release) INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a … |
View full post on asthma – Google News
|
SPIRIVA ® RESPIMAT ® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents
Business Wire (press release) INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that SPIRIVA® RESPIMAT® is now available for the treatment of asthma by prescription in U.S. pharmacies. The U.S. Food and Drug Administration (FDA) approved a … SPIRIVA RESPIMAT Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents |
View full post on asthma – Google News
|
Research and Markets: Preventive Asthma Drug Market Outlook 2020 – Showing …
Business Wire (press release) Asthma is showing high prevalence worldwide. About 300 Million people are suffering from asthma. This is due to continuously deteriorating air quality, which is causing several allergies. In recent years, researchers have explored wide variety of … Global Insulin API Market 2015 Industry Key Trends, Demand, Growth, Size … |
View full post on asthma – Google News
|
Research and Markets: Europe Asthma Market Report – Analysis, Technologies …
Business Wire (press release) The latest research, 'Europe Asthma Market Highlights – 2015', provides asthma market analysis, competitive landscape, and asthma drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain … |
View full post on asthma – Google News
|
Research and Markets: Global Preventive Asthma Drugs Market 2015-2019
Business Wire (press release) The global preventive asthma drugs market is expected to grow at a CAGR of 5.20% over the period 2014-2019. The report, Global Preventive Asthma Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from … |
View full post on asthma – Google News
Indie Wire (blog) |
Review: Jake Hoffman's Obvious And Tiresome 'Asthma' With Krysten Ritter, Iggy …
Indie Wire (blog) It's really a win/win situation. If the logline “examines the consequences of the 'live fast, die young' mentality in New York's indie rock scene” doesn't chill you to your core, perhaps you might actually get something out of “Asthma,” the directorial … Jake Hoffman Wants to Show Both Sides of Rebellion and Addiction in As |
View full post on asthma – Google News
|
Research and Markets: Global Asthma & COPD Market Report: 2015 Edition …
Business Wire (press release) The leading players operating in the industry include AstraZeneca, Merck and Co., Roche, Sanofi and Novartis which are also profiled in this report. The present report provides a comprehensive analysis of the global asthma & COPD market with focus on … |
View full post on asthma – Google News